Extended-duration topical flea and tick protection for cats
Benefits of BRAVECTO® Topical Solution for Cats
Long-lasting flea and tick protection
- Guaranteed fast-acting protection that lasts 12 weeks*
- The safe, innovative formula is applied topically on cats, but like the oral chew for dogs, it works systemically1
- Available by veterinary prescription only
Improve pet owner compliance
- A single dose provides 12 weeks* of protection
- Administering fewer doses per year helps reduce stress on cats and their owners, versus monthly products
- Extended-duration protection makes continuous coverage easier to achieve
- Easy-to-use applicator makes administration convenient for pet owners
Trusted active ingredient
- Fluralaner, an ectoparasiticide belonging to the isoxazoline group
- Systemically active against fleas and ticks for 12 weeks*
- Starts killing within 2 hours after administration1 for quick flea control
Indications
BRAVECTO Topical Solution for Cats kills adult fleas and is indicated for the treatment and prevention of flea infestations (Ctenocephalides felis) and the treatment and control of Ixodes scapularis (black-legged tick) and Haemaphysalis longicornis (Asian longhorned tick) infestations for 12 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater.
BRAVECTO Topical Solution for Cats is also indicated for the treatment and control of Dermacentor variabilis (American dog tick) infestations for 8 weeks in cats and kittens 6 months of age and older, and weighing 2.6 pounds or greater.
Prescribe BRAVECTO based on the patient’s weight1
One application per weight
† Cats over 27.5 pounds should be administered the appropriate combination of tubes.
More continuous coverage with 12 long weeks* of protection
Make every dose last ~3X* longer† with BRAVECTO Topical Solution for Cats1
*BRAVECTO (fluralaner topical solution) for Cats kills fleas, prevents flea infestations, and kills ticks (black-legged tick and Asian longhorned tick) for 12 weeks. BRAVECTO Topical Solution for Cats also kills American dog ticks for 8 weeks.
† BRAVECTO Topical Solution for Cats should be administered every 12 weeks.
BRAVECTO Topical Solution: Persistent efficacy against fleas1,2
FLEA EFFICACY FOR CATS FOR UP TO 12 WEEKS1,2 *
BRAVECTO efficacy in killing fleas and stopping flea infestations was evaluated in a 12-week multicenter, clinical field study.2 Results showed that:
- One dose of BRAVECTO reduced fleas by >98% within 12 hours for 12 weeks1,2 *
- BRAVECTO acts quickly, with 100% of fleas killed 8 hours after treatment1
- In a separate study, 81%-100% of felines with signs attributed to FAD treated with BRAVECTO had resolution of the following signs by the end of the study:3
- Erythema, papules, crusts, alopecia, scales, excoriation
The 12-week* difference against ticks1,4
TICK PROTECTION IN CATS
BRAVECTO (fluralaner) tick protection efficacy was evaluated in 12-week clinical field studies. Against black-legged ticks, BRAVECTO had >94% effectiveness 48 hours postinfestation for 12 weeks.1,4
In a separate study BRAVECTO showed >98% effectiveness against American dog ticks 48 hours postinfestation for 8 weeks.1,5
BRAVECTO Topical Solution is proven safe
No known contraindications for BRAVECTO Topical Solution for Cats.1
No problems reported in field trials in cats that received BRAVECTO concurrently with other commonly used medication.1
BRAVECTO has not been shown to be effective for 12 weeks duration in kittens less than 6 months of age.1
In field studies and safety studies, no cats experienced serious adverse events.1,6
BRAVECTO is safe to use and efficacious in adult cats and kittens over 6 months of age and weighing 2.6 pounds or greater. It has been tested and found safe in kittens at least 11 to 13 weeks of age at 5X the clinical dose.1
Discover the 12-week* difference
Ask your Merck Animal Health representative or reach out to us for more information about BRAVECTO topical flea and tick treatment for your hospital.
We’ll answer any questions and help you start prescribing BRAVECTO for the cats in your care.
Frequently Asked Questions about BRAVECTO Topical Solution for Cats
In a well-controlled European laboratory study, BRAVECTO killed 100% of fleas 8 hours after treatment and reduced the number of live fleas on cats by >98% within 12 hours after treatment or postinfestation for 12 weeks. BRAVECTO demonstrated >94% effectiveness against Ixodes scapularis and Haemaphysalis longicornis 48 hours postinfestation for 12 weeks and >98% effectiveness against Dermacentor variabilis 48 hours postinfestation for 8 weeks.1
Extended-duration protection makes it easier and more convenient for pet owners to give their cat doses on time, leading to fewer gaps in protection. Both BRAVECTO Topical Solution for Cats and BRAVECTO® PLUS provide effective, fast-acting 12-week* protection. Talk with pet owners about what solution works best for their situation and their cat to ensure better compliance.
For technical assistance or to report a suspected adverse drug reaction, contact Merck Animal Health at 1-800-224-5318.
This site is intended for veterinary professionals. Visit our website for pet owners.
* BRAVECTO kills fleas and prevents flea infestations. BRAVECTO (fluralaner topical solution) for Cats kills ticks (black-legged tick and Asian longhorned tick) for 12 weeks. BRAVECTO Topical Solution for Cats also kills American dog ticks for 8 weeks.
Important Safety Information
BRAVECTO (fluralaner topical solution) for Cats: The most commonly reported adverse reactions include vomiting, itching, diarrhea, hair loss, decreased appetite, lethargy, and scabs/ulcerated lesions. BRAVECTO Topical Solution for Cats is not effective against American dog ticks beyond 8 weeks of dosing. BRAVECTO PLUS (fluralaner and moxidectin topical solution) for Cats: The most commonly reported adverse reactions include vomiting, hair loss, itching, diarrhea, lethargy, dry skin, elevated ALT, and hypersalivation. BRAVECTO PLUS has not been shown to be effective for 2 months in kittens less than 6 months of age. Use with caution in cats that are heartworm positive. The effectiveness of BRAVECTO PLUS to prevent heartworm disease after bathing or water immersion has not been evaluated.
BRAVECTO Topical Solution for Cats and BRAVECTO PLUS for Cats are for topical use only. Avoid oral ingestion. The safety of BRAVECTO Topical Solution for Cats and BRAVECTO PLUS have not been established in breeding, pregnant, and lactating cats.
All BRAVECTO products contain fluralaner, which is a member of the isoxazoline class. This class has been associated with neurologic adverse reactions including tremors, ataxia, and seizures. Neurologic adverse reactions have been reported in cats receiving isoxazoline class drugs, even in cats without a history of neurologic disorders. Use with caution in cats with a history of neurologic disorders.
References
- BRAVECTO® Topical Solution for Cats. Product label. Merck Animal Health; 2022.
- BRAVECTO Topical Solution for Dogs and Cats. Freedom of Information Summary NADA 141-459 (Study S11287-00). July 20, 2016. Accessed February 12, 2025. July 20, 2016. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/945
- BRAVECTO Topical Solution for Dogs and Cats. Freedom of information Summary. NADA 141-459 (Study S11158-00). July 20, 2016. Accessed February 12, 2025. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/945
- BRAVECTO Topical Solution for Dogs and Cats. Freedom of information Summary. NADA 141-459 (Studies S11123-04, S11123-05). July 20, 2016. Accessed February 12, 2025. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/945
- BRAVECTO Topical Solution for Dogs and Cats. Freedom of information Summary. NADA 141-459 (Study S11175-02). July 20, 2016. Accessed February 12, 2025. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/945
- BRAVECTO Topical Solution for Dogs and Cats. Freedom of information Summary. NADA 141-459. July 20, 2016. Accessed February 12, 2025. https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/945
All trademarks are the property of their respective owners.